Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Open-market sale President sold 1,338 shares at $17.41 ($23,295)
  2. 4 Open-market sale CEO sold 2,963 shares at $17.41 ($51,586)
  3. 4 Option exercise Director acquired 1,918 shares (option exercise)
  4. 8-K Event Executive or director change
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations
  7. 8-K Event Shareholder vote results
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Grant or award Director acquired 25,564 shares (grant or award)
  14. DEFR14A Other DEFR14A
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. 4 Open-market sale EVP and CFO sold 1,032 shares at $20.33 ($20,981)
  18. 4 Open-market sale EVP & General Counsel sold 1,054 shares at $20.33 ($21,428)
  19. 4 Open-market sale President sold 4,230 shares at $20.33 ($85,996)
  20. 4 Open-market sale CEO sold 7,850 shares at $20.33 ($159,591)

Page 18 of 70 · 1,382 filings